BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3907307)

  • 1. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin.
    Weber G; Lui MS; Jayaram HN; Pillwein K; Natsumeda Y; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1985; 23():81-99. PubMed ID: 3907307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery.
    Chapman AG; Westerberg E; Siesjö BK
    J Neurochem; 1981 Jan; 36(1):179-89. PubMed ID: 7463044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine metabolism of human glioblastoma in vivo.
    Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
    Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin regulatory effects on purine- and pyrimidine metabolism in alloxan diabetic rat liver.
    Pillwein K; Reardon MA; Jayaram HN; Natsumeda Y; Elliott WL; Faderan MA; Prajda N; Sperl W; Weber G
    Padiatr Padol; 1988; 23(2):135-44. PubMed ID: 3043317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN
    Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in levels of purine and pyrimidine nucleotides during acute hypoxia and recovery in neonatal rat brain.
    Hisanaga K; Onodera H; Kogure K
    J Neurochem; 1986 Nov; 47(5):1344-50. PubMed ID: 3020172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E; Kremmer T; Boldizsár M
    Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine de novo synthesis in liver and developing rat brain, and the effect of some inhibitors of purine nucleotide interconversion.
    Allsop J; Watts RW
    Enzyme; 1983; 30(3):172-80. PubMed ID: 6628351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation.
    Hatse S; De Clercq E; Balzarini J
    Biochem Pharmacol; 1999 Aug; 58(4):539-55. PubMed ID: 10413291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolbutamide attenuates diazoxide-induced aggravation of hypoxic cell injury.
    Pissarek M; Reichelt C; Krauss GJ; Illes P
    Brain Res; 1998 Nov; 812(1-2):164-71. PubMed ID: 9988561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.